Depression, suicidal
ideation, and suicide attempts have been reported to occur with
increased frequency in patients receiving interferon compounds
to treat multiple sclerosis.
The potential of additive (combined) effects from multiple drugs
or other hepatotoxic agents (liver damaging substance; e.g. alcohol)
has not been determined.
